CE: Psychedelic-Assisted Therapy
Level 5 - mechanism / opinion, no new human data
Narrative continuing-education review and expert commentary without new human data or systematic synthesis.
OpenAlex W3160306775 · doi:10.1097/01.naj.0000753464.35523.29
What was done
This continuing education article reviews the historical context of psychedelic research between 1943 and the early 1970s and outlines educational and professional steps for nurses preparing for the clinical re-emergence of psychedelic-assisted therapy.
What was found
The abstract reports no empirical data or quantitative findings. It provides qualitative guidance recommending that nurses learn relevant history, language, and scientific findings, explore therapeutic resources, examine personal opinions regarding psychedelics, and evaluate potential future nursing roles.
Why it matters
As psychedelic-assisted therapies approach potential integration into clinical psychiatric care, this article frames the educational and professional competencies needed by nursing staff.
Limits
This is a narrative educational commentary and opinion piece. It presents no original empirical data, quantitative measurements, or systematic review methodology.
Cited by
- supports Richard Nixon's Controlled Substances Act of 1970 virtually shut down research on psychedelic therapies.